Searched for
PHARMA STOCK UPDATE
Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...- Sensex rises 291 points, Nifty closes above 24,100; Tech Mahindra, Sun Pharma among top gainersIndian stock markets saw a positive start on Monday, with Sensex and Nifty inching up after Friday's dip. Tech Mahindra led the gains, whil...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27%The US-Iran peace deal is finally about to happen. There is a high probability that global markets will see a relief rally, a part of which...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- Markets rebound sharply: Sensex recovers 1,100 points from day’s low, Nifty closes near 23,650Sensex rose 1,100 points from its day’s low to close at 75,315, and Nifty 50 gained 333 points from its day’s low to end the session at 23,...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- Stock Market Crash Today: D-Street investors lose Rs 5 lakh crore. 7 reasons why Sensex and Nifty fellIndian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...
- Why stock market fell today? Sensex plunges 850 pts, Nifty below 24,200. 6 reasons behind selloffIndian equity benchmarks declined for a second straight session, pressured by a spike in crude oil prices, a weakening rupee and rising geo...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- Why stock market rose today? Sensex jumps 500 points, Nifty settles above 24,350. 5 key factors explainedIndian stock markets saw significant gains on Friday. The Sensex and Nifty closed the week over 2% higher. This recovery follows a March se...
- Windlas Biotech announces Rs 47 crore buyback at Rs 1,000/share; sets April 24 as record dateWindlas Biotech approved a Rs 47 crore share buyback at Rs 1,000 per share via the tender route, with April 24 set as the record date. The ...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- RBL Bank shares jump 4% after exceptional Q4 update, RBI’s approval for Emirates NBD’s 74% stake acquisitionRBL Bank shares rose sharply on Monday after strong Q4 business numbers and the RBI’s nod for Emirates NBD to acquire up to 74% stake in th...
- DMart shares jump 4% after strong Q4 update, but JM Financial calls risk-reward ratio unattractive; here's whyAvenue Supermarts' shares saw a jump after reporting a 19% year-on-year revenue increase for the January-March quarter of FY26. The company...
- Stock Radar: 60% rally in a year! This pharma stock is likely to continue its winning runSun Pharma's stock price has surged over 60% in the past year, hitting a record high of Rs 1,960 on September 30th. Though profit-taking ha...
- On a path to recovery; 6 mid-cap pharma stocks including 2 MNC’s with an upside potential up to 29%After witnessing a phase of under-performance, select pharma stocks had been making a comeback. The list includes MNC pharma companies whic...
- Gland Pharma loses 24% of its value in 3 days. What's spooking investors?Gland Pharma said revenue from its core markets of the US, Europe, Canada and Australia grew by 3 per cent to Rs 747.5 crore in the second ...
- 4 reasons analysts are bullish on Gland Pharma stockGrowth of injectables in the pharmaceutical market, strong R&D capabilities and the probablity of starting a business with China that has a...
- Aurobindo Pharma skids 3% as drugmaker plans to sell 30-35% stake in injectable businessTPG Capital Management, Advent International, Bain Capital and Blackstone have been sounded off for a potential transaction, valuing the bu...
- Ajanta Pharma board approves up to Rs 286-crore share buyback planThe total pay-out towards buyback of shares will be not exceeding Rs 356 crore, including a share buyback consideration not exceeding Rs 28...
Load More
